Ascendis Pharma A (ASND) Equity Ratio (2012 - 2025)

Ascendis Pharma A has disclosed Equity Ratio across 14 years of filings, most recently posting 0.12 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.12, down 271.92% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.12 (down 271.92% YoY), and the FY2025 annual result was 0.12, down 271.92% from the prior year.
• Equity Ratio came in at 0.12 for Q4 2025 at Ascendis Pharma A, down from 0.03 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.83 in Q1 2021 to a low of 0.18 in Q4 2023.
• The 5-year median for Equity Ratio is 0.35 (2022), against an average of 0.31.
• Across the five-year window, Equity Ratio jumped 80.96% in 2024 and slumped 271.92% in 2025, its largest moves.
• Ascendis Pharma A's Equity Ratio stood at 0.44 in 2021, then tumbled by 45.36% to 0.24 in 2022, then sank by 173.03% to 0.18 in 2023, then surged by 80.96% to 0.03 in 2024, then slumped by 271.92% to 0.12 in 2025.
• The last three Equity Ratio figures came in at 0.12 (Q4 2025), 0.03 (Q4 2024), and 0.18 (Q4 2023), per Business Quant data.